Stay informed with the latest litigation news. Explore now

IP Verse

Duke University competitive analysis

Latest publications and patents of Duke University New

Explore the latest publications and patents granted to Duke University, showcasing their recent innovations and technological advancements.

Last updated on: Sep 12, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Duke University

EP3823992
Dec 13, 2023Anti-Lypd3 Car T-Cell Therapy For The Treatment Of CancerGranted And Under Opposition
EP3773486
Dec 6, 2023Methods Of Treating Autism Spectrum Disorders Using Human Umbilical Cord Tissue-Derived Mesenchymal Stromal CellsGranted And Under Opposition
EP3122426
Jan 18, 2023Method Of Treating Cancer Using Selective Estrogen Receptor ModulatorsGranted And Under Opposition
EP3360979
May 20, 2020Tert Promoter Mutations In Gliomas And A Subset Of TumorsRevoked
EP2884272
Jan 3, 2018Method For Splitting Droplets By Electrowetting-Based TechniquesNo Opposition Filed Within Time Limit
EP1667714
Jan 3, 2018Consensus/Ancestral ImmunogensNo Opposition Filed Within Time Limit
EP2011034723
Mar 24, 2011Improved Device And Method For Delivery Of A Medicament -
EP2010107613
Sep 23, 2010Tobacco-Based Nicotine Aerosol Generation System -
EP2008121610
Oct 9, 2008Device And Method For Delivery Of A Medicament -
EP2008241255
Oct 2, 2008Device And Method For Delivery Of A Medicament -

Latest patents of Duke University opposed by its competitors

Explore Duke University's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 18, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3823992
Dec 13, 2023Anti-Lypd3 Car T-Cell Therapy For The Treatment Of Cancer1
EP3773486
Dec 6, 2023Methods Of Treating Autism Spectrum Disorders Using Human Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells1
EP3122426
Jan 18, 2023Method Of Treating Cancer Using Selective Estrogen Receptor Modulators2
EP3360979
May 20, 2020Tert Promoter Mutations In Gliomas And A Subset Of Tumors1

Latest PTAB cases involving Duke University New

Discover the latest PTAB cases involving Duke University, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 18, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Duke University

IPR2013-00535Aug 28, 2013BIOMARIN PHARMACEUTICALDUKE UNIVERSITYFinal Written Decision

Top competitors of Duke University

Top competitors of Duke University based on patent oppositions.